The Discounted Cash Flow (DCF) valuation of EyePoint Pharmaceuticals Inc (EYPT) is (93.38) USD. With the latest stock price at 13.35 USD, the upside of EyePoint Pharmaceuticals Inc based on DCF is -799.5%.
Based on the latest price of 13.35 USD and our DCF valuation, EyePoint Pharmaceuticals Inc (EYPT) is a sell. selling EYPT stocks now will result in a potential gain of 799.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 7.1% | 6.1% |
| Long-term Growth Rate | 3.0% - 4.8% | 3.9% |
| Fair Price | (801.22) - (50.57) | (93.38) |
| Upside | -6101.7% - -478.8% | -799.5% |